Backtracing persistent biomarker shifts to the age of onset: A novel procedure applied to men’s and women’s white blood cell counts in post-traumatic stress disorder by Ajdacic-Gross, Vladeta et al.








Backtracing persistent biomarker shifts to the age of onset: A novel
procedure applied to men’s and women’s white blood cell counts in
post-traumatic stress disorder
Ajdacic-Gross, Vladeta ; Ajdacic, Lena ; Xu, Yanhua ; Müller, Mario ; Rodgers, Stephanie ; Wyss,
Christine ; Olbrich, Sebastian ; Buadze, Anna ; Seifritz, Erich ; Wagner, En-Young N ; Radovanovic,
Dragana ; von Wyl, Viktor ; Steinemann, Nina ; Landolt, Markus A ; Castelao, Enrique ; Strippoli,
Marie-Pierre F ; Gholamrezaee, Mehdi M ; Glaus, Jennifer ; Vandeleur, Caroline ; Preisig, Martin ; von
Känel, Roland
Abstract: Background: Traumatic experiences tend to be preserved in altered biomarker profiles. These
profiles can be traced back from cross-sectional data regarding the age of exposure. Consequently, the
change across developmental stages, e.g. from childhood to adulthood, can also be reconstructed. This
study introduces a backtrace procedure that is illustrated using white blood cell (WBC) counts in full
/ partial post-traumatic stress disorder (PTSD). The procedure was applied separately on men’s and
women’s data to provide a replication of the analysis based on different subsamples. Methods: The
analysis was carried out with data from the CoLaus|PsyCoLaus study (N = 5111, 2370 men and 2741
women, age range 35–88 years). It was restricted to traumatic experiences that occurred until the age of
35, i.e., the lower age limit of the sample. The WBC counts from up to two assessments were standardized,
pooled and assigned to the reported age of trauma exposure. This resulted in age series for each marker,
whereas the reference values were based on subjects who did not experience any trauma exposure. The
backtrace procedure ascertained the peaks and troughs of the age series and determined the best-fitting
critical age range surrounding each peak or trough based on the best p-value from simple t-tests. Results:
In CoLaus|PsyCoLaus, 750 participants reported trauma exposure until the age of 35, and 86 (out of
329) men and 187 (out of 421) women thereof were coded with a full or partial PTSD. Full / partial
PTSD after trauma exposure in childhood was characterized by increased WBC counts (lymphocytes,
eosinophils – in women also neutrophils). This pattern was partly retained during adolescence, in men
due to eosinophils counts and in women due to lymphocyte counts. For exposure in young adulthood,
the deviations were in the negative direction – in men with decreased basophils, in women with decreased
lymphocytes and monocytes. Conclusions: Summarizing, the backtrace approach revealed WBC profiles
in PTSD that were specific to particular developmental age stages. The strongest persistent upregulation
of the immune system related to trauma exposure was traceable to childhood / early adolescence both in
men and in women. Further research will show which biomarkers are similarly suitable for backtracing
as WBC counts. As in PTSD, the backtrace approach could also be applied to identifying persistent
biomarker profiles in other mental disorders, as well as autoimmune and other chronic diseases.
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A B S T R A C T
Background: Traumatic experiences tend to be preserved in altered biomarker profiles. These profiles can be traced
back from cross-sectional data regarding the age of exposure. Consequently, the change across developmental
stages, e.g. from childhood to adulthood, can also be reconstructed. This study introduces a backtrace procedure that
is illustrated using white blood cell (WBC) counts in full / partial post-traumatic stress disorder (PTSD). The
procedure was applied separately on men's and women's data to provide a replication of the analysis based on
different subsamples.
Methods: The analysis was carried out with data from the CoLaus|PsyCoLaus study (N = 5111, 2370 men and 2741
women, age range 35–88 years). It was restricted to traumatic experiences that occurred until the age of 35, i.e., the
lower age limit of the sample. The WBC counts from up to two assessments were standardized, pooled and assigned to
the reported age of trauma exposure. This resulted in age series for each marker, whereas the reference values were
based on subjects who did not experience any trauma exposure. The backtrace procedure ascertained the peaks and
troughs of the age series and determined the best-fitting critical age range surrounding each peak or trough based on
the best p-value from simple t-tests.
Results: In CoLaus|PsyCoLaus, 750 participants reported trauma exposure until the age of 35, and 86 (out of 329)
men and 187 (out of 421) women thereof were coded with a full or partial PTSD. Full / partial PTSD after trauma
exposure in childhood was characterized by increased WBC counts (lymphocytes, eosinophils – in women also
neutrophils). This pattern was partly retained during adolescence, in men due to eosinophils counts and in women
due to lymphocyte counts. For exposure in young adulthood, the deviations were in the negative direction – in men
with decreased basophils, in women with decreased lymphocytes and monocytes.
Conclusions: Summarizing, the backtrace approach revealed WBC profiles in PTSD that were specific to particular
developmental age stages. The strongest persistent upregulation of the immune system related to trauma exposure
was traceable to childhood / early adolescence both in men and in women. Further research will show which
biomarkers are similarly suitable for backtracing as WBC counts. As in PTSD, the backtrace approach could also be
applied to identifying persistent biomarker profiles in other mental disorders, as well as autoimmune and other
chronic diseases.
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Introduction
Post-traumatic stress disorder (PTSD) is a mental disorder that can be
triggered by exposure to a traumatic or stressful event. Biomarker
research in PTSD has two typical methodological scenarios. One of them
aims at timely measurement after exposure to a traumatic event, either
supplemented or not by prospective measurements. The other scenario –
delayed measurement – focusses on persistent shifts in biomarker levels,
either within a chronic posttraumatic condition or based on the idea of
"frozen markers". The latter assumes that shifted markers are detectable
even after the remission of post-traumatic symptoms. This reasoning can
be broadly extended to other mental disorders and their onset. However,
methodological approaches that take advantage of the wealth of "frozen
markers" data are needed in PTSD research as in other research domains.
In the following, we present a novel approach, the backtrace procedure.
In PTSD, the "frozen markers" concept implies that traumatic
experiences are preserved in altered biomarker profiles that could be
reconstructed years or even decades after trauma-inducing exposure. A
preliminary impression of heterogeneous "freezing" outcomes emerges
from the study of Vidovic et al. [1], who examined a series of markers in
combat veterans with PTSD 6 and 11.5 years after the traumatic
experience. While prolactin and overall lymphocyte counts remained at
increased levels at the second measurement, other markers (cortisol
levels, natural killer cell cytotoxicity, glucocorticoid receptor expression)
returned to levels similar to those measured in controls. In other studies,
heart rate and blood pressure have been documented to remain shifted
across time / age [2].
From a methodological perspective, the "frozen markers" concept
opens up interesting perspectives for retrospective analyses based on
cross-sectional data. First of all, it helps to overcome the typical limitation
of longitudinal studies to short prospective observation periods and / or to
specific age groups. In addition, the analysis of "frozen markers" in large
cross-sectional databases allows the assessment of long-range changes
between generations and, more importantly, age-of-onset-dependent
processes. With the latter, the study of developmental stages [3] also
becomes an attainable target.
In this study, a novel methodological procedure was developed to
trace persistently shifted markers in cross-sectional data back to the age of
onset. The backtrace procedure is illustrated by white blood cell (WBC)
counts in full / partial PTSD. PTSD was chosen since, as Pitman et al. [4]
pointed out, "PTSD is the only major mental disorder for which a cause is
considered to be known". An unequivocal exogenous trigger (trauma) and
relatively unambiguous information about the age of onset (age of trauma
exposure) are crucial for demonstrating the procedure. Moreover, the
procedure was applied separately on men's and women's data to provide a
replication of the analysis based on different subsamples, which was
preferred over a reliability procedure such as split-half. The database




Data used for the current study were derived from the population-based
longitudinal study CoLaus|PsyCoLaus [5,6]. The CoLaus|PsyCoLaus study
was designed to explore the associations between mental disorders and
cardiovascular diseases. The cohort was randomly selected from the 35- to
75-year-old residents of the city of Lausanne (Switzerland) from 2003 to
2006, according to the civil register. The initial cohort included 6734
people. Fig. 1 displays the overall workflow of the sampling process. The
first follow-up (FU1) was carried out between 2009–2013 and the second
follow-up (FU2) was conducted between 20142018.
At baseline, the psychiatric evaluation was restricted to the 35- to 66-
year-old participants in the physical exam, resulting in a 67 %
participation within this age range (N = 3719). From FU1 on, all
individuals from the initial cohort were eligible for psychiatric
evaluation. The cohort used in the present paper is comprised of the
first assessment of all 5111 people who agreed to at least one psychiatric
evaluation (3719 at baseline, 1155 at FU1, 237 at FU2).
Instruments
The French version [7] of the semi-structured Diagnostic Interview for
Genetic Studies (DIGS) [8], was used for collecting diagnostic informa-
tion on mental disorders. The assessments covered a broad spectrum of
the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV Axis I
criteria, as well as the course and chronology of comorbid features [7].
The French version of the DIGS revealed excellent inter-rater reliability in
terms of kappa and Yule's Y coefficients for major mood and psychotic
Fig. 1. The overall workflow of the CoLaus|PsyCoLaus sampling.
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disorders as well as for substance use and antisocial personality disorders,
whereas the 6-week test-retest reliability was slightly lower [7,9]. The
DIGS was completed with the PTSD and the generalized anxiety disorder
(GAD) sections of the French version [10] of the Schedule for Affective
Disorders and Schizophrenia - Lifetime and Anxiety disorder version
(SADS-LA) [11], and the brief phobia chapter of the DIGS was replaced by
the corresponding, more extensive chapters of the SADS-LA which
elicited detailed information relating to the DSM-IV criteria for
agoraphobia with or without panic attacks, social and specific phobias.
These anxiety disorders also revealed satisfactory test-retest reliability
[10,12].
Information regarding the nature of potentially traumatic events as
well as subsequent PTSD symptoms was extracted from the PTSD section
of the interview. Five types of traumatic events were assessed based on the
SADS-LA: 1) accident or severe catastrophe, 2) active combat or war, 3)
witnessing trauma to others, and 4) violent crime, and 5) sexual trauma.
Sexual trauma including rape, sexual abuse and exhibitionism was
evaluated and coded separately. If a subject reported several events, he /
she was asked to identify the most upsetting one and to indicate the age of
first exposure to this event. Age of first sexual abuse was asked separately.
All associations with single traumatic events are in relation to this specific
event. The test-retest reliability for the PTSD diagnosis was estimated at
Yule = 0.69 from a sample of 176 psychiatric patients [13].
In this analysis, PTSD was pooled with partial PTSD in order to achieve
subsamples of reasonable size. Partial PTSD was defined according to
Breslau et al. [14] by the presence of at least one symptom in each of the
PTSD criteria B (re-experience), C (avoidance of stimuli), D (increased
arousal) and the duration of at least one month.
Morning venous blood samples served to assess WBCs apart from other
markers (inflammatory, cardio-metabolic; for more details see [5]).
EDTA blood was used to assess WBC counts. WBC counts were obtained on
a Sysmex XE-2100 and XE-5000 apparatus (Sysmex, Horgen,
Switzerland) [15] using fluorescent flow cytometry with light scattering
as a principle for differential and total leukocyte count. Neutrophils,
lymphocytes, monocytes, eosinophils and basophils were computed, both
as absolute values and as proportions of the total WBC count, and results
were outputted directly from the apparatus.
WBCs were assessed twice, that is, at the follow-ups to CoLaus|
PsyCoLaus. Neutrophils, lymphocytes, monocytes, eosinophils and
basophils were computed, both as absolute values and as proportions of
the total WBC count. In the analyses, we considered both parameters to see
the full picture. Using only proportions or combined parameters such as the
neutrophil-to-lymphocyte ratio [16] limits the range of relations that can
be detected in the analysis (see, for example, the increased levels of
neutrophils and lymphocytes in women as reported in the Results section).
All data preparation steps and all subsequent analyses were conducted
separately for men and women. The Kolmogorov-Smirnov and the
Shapiro-Wilk test served to check for the normal distribution of the WBC
variables. If appropriate, the variables were smoothed, i.e., transformed
by log or square root. Values were considered as outliers if above / below 3
standard deviations (SD) and were set to missing. In the next step, the
variables were submitted to z-transformation. This enabled the averaging
of the variables if data from two measurements were available. Finally,
the variables were age-standardized using a linear or quadratic
regression, if appropriate, in order to exclude bias related to different
age patterns of WBC variables (referring to the age at measurement).
The analyses were limited to trauma exposures that occurred up to the
age of 35. This is at the same time the youngest age of the participants at
the baseline examination (see above).
The backtrace procedure to determine peaks and troughs and related critical
age periods
The different analysis steps of the procedure are shown in a flow chart
(Fig. 2). After pre-processing the data (step 1, see data preparation
above), each WBC variable was first analyzed in the conventional way – t-
test based on overall data – to provide a benchmark for the results from
the backtrace procedure.
The basic idea behind the procedure is, in brief, to trace the values for a
marker back to the age of trauma exposure. Thus, instead of an overall
mean as in step 2, we obtain a curve representing the fluctuations in the
marker back to age of exposure. From this curve, we want to determine
whether the fluctuations comprise periods of significantly increased (or
decreased) marker values. Therefore, we first identify the peak and trough
values of the curve, together with the age of exposure (step 3). If a peak or
a trough significantly deviates from the reference value, we next take aim
at the "critical" age range during which the deviation is in effect (step 4). A
more detailed description of steps 3–4 follows below. The "critical" age
ranges of several markers can be assembled in a descriptive graphic
analysis (step 5) and can be used in any subsequent analyses (step 6).
In detail, steps 3 and 4 each comprise several intermediate steps. In the
current application, the traced back WBC values were averaged in step 3
and displayed by age of exposure (based on yearly values). Thus, the
resulting curve in fact represented a time series with age as the x-axis.
Because of the strong fluctuations of the yearly values, the curve was
smoothed by applying moving averages, i.e., by grouping the data into n-
year age windows (also known as the sliding window approach). Peak and
trough values were determined from the smoothed curves. They were
compared with the reference value, which basically represents the overall
mean level of the same marker in subjects who did not experience any
trauma – here calculated after transformation and standardization (see
above) and therefore close to 0.
A WBC variable was selected for further analysis in step 4 in two
instances:
 if a peak or trough (or both) returned significant deviations from the
reference value as indicated by t-tests;
 if the overall t-test in step 2 had yielded a significant result, for example
due to a substantial shift of WBC levels without marked fluctuations
across age.
Fig. 2. Flow chart of the analysis steps.
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In both instances, the peak (and / or trough) was chosen as the starting
point for step 4 of the procedure.
The purpose of step 4 was to determine the best-fitting critical age
range surrounding each peak or trough. That is, the step 3 analysis was
extended by letting the age windows flexibly vary around a selected peak
/ trough. Therefore, instead of fixed intervals such as in the moving
average approach, each possible age range around a selected peak (or
trough) was now checked by applying t-tests. The best (lowest) p-value
from these tests was used as a preliminary indicator of the most suitable
critical age range. Exclusion criteria at that step were a small N (< 10) and
a short age range (< 5 years), which are assumed to be indicative of
outliers.
Steps 3 and 4 were repeated starting with different moving averages:
with 3- and 5-year windows. This was necessary since different moving
averages can return different peaks (or troughs). In cases of diverging
results from different runs, again the one with the best p-value was chosen
for further analysis. A more detailed description of the steps 3 and 4 of the
backtrace procedure illustrated by an example can be found in the
Appendix.
Statistical analysis and programming
In steps 2–4 of the procedure, we applied simple t-tests. The results
based on the 0.01 p-value served as reference for interpretation. Results
based on the 0.05 p-value were also documented and used in a
supplementary way for pattern recognition purposes, for example, to
visualize critical age periods (step 5). Due to the exploratory nature of this
analysis, we explicitly refrained from performing adjustments for
multiple testing in analyses of heterogeneous conditions, as in pattern
recognition analyses such as LCA and in other exploratory analyses (see
also [17]).
Programming and the analyses were carried out with Stata (Version
15); the basic preparation of the data, with SPSS Statistics (Version 23).
Ethics approval
The Institutional Ethics Committee of the University of Lausanne
approved the CoLaus|PsyCoLaus study [5,6]. All participants signed a
written informed consent form after receiving a detailed description of
the goal, procedures and funding of the study.
Results
In CoLaus|PsyCoLaus, 960 (19.0 %) participants reported having
experienced a trauma and specified one of the trauma subtypes. Of these,
425 (18.2 %) were male and 535 (19.9 %) were female. Furthermore, 329
men and 421 women were younger than or equal to 35 years at trauma
exposure, and 86 men and 187 women thereof were coded with a partial
(N = 47 and 87) or full PTSD (N = 39 and 100).
The descriptive parameters of each WBC count per interview in overall
data are summarized in Table 1, and the averaged z-standardized values
of persons with partial / full PTSD in Table 2. The measures were in the
expected range, here exemplified by percentage values of WBC in men
and women (Table 1): 54.4–56.9 % and 55.1–56.7 % in neutrophils, 29.8–
32.2 % and 31.3–33.0 % in lymphocytes, 9.2 % and 8.2 % in monocytes,
3.1–3.2 % and 2.7 % in eosinophils, 0.6–0.8 % in basophils.
As Table 2 additionally shows, after pre-processing of the data, the
comparisons with subjects without trauma exposure yielded significant t-
test results in neutrophils (decreased levels of counts and proportions)
counterbalanced by lymphocytes (increased proportions). In women,
leukocyte together with neutrophil levels were increased, whereas
monocyte proportions were decreased.
After the analyses were differentiated by age of trauma exposure with
the backtrace procedure, distinctly more significant results emerged
related to specific critical age ranges (Table 3). In some instances, non-
significant associations from the analysis with overall data even switched
to strongly significant ones. Moreover, in one instance (lymphocyte
Table 1
Descriptives of white blood cell counts in men and women, by measurement.
1st follow-up measurement 2nd follow-up measurement units data transformation *
N mean SE N mean SE
men**
leukocytes 1349 6.43 0.0556 1692 6.20 0.0442 G/l log
basophils 1347 0.034 0.0006 1675 0.046 0.0007 G/l square root
basophils % 1347 0.0056 0.0001 1675 0.0076 0.0001 % square root
eosinophils 1348 0.20 0.0034 1675 0.190 0.0030 G/l square root
eosinophils % 1348 0.032 0.0005 1675 0.031 0.0004 % square root
lymphocytes 1347 2.018 0.0195 1675 1.810 0.0200 G/l square root
lymphocytes % 1347 0.322 0.0022 1675 0.298 0.0020 % –
monocytes 1347 0.586 0.0053 1675 0.5603 0.0044 G/l square root
monocytes % 1347 0.092 0.0007 1675 0.0917 0.0005 % square root
neutrophils 1347 3.541 0.0377 1675 3.584 0.0335 G/l square root
neutrophils % 1347 0.544 0.0024 1675 0.569 0.0022 % –
women***
leukocytes 1614 6.190 0.0518 2101 6.097 0.0495 G/l log
basophils 1613 0.035 0.0005 2063 0.046 0.0007 G/l square root
basophils % 1613 0.006 0.0001 2063 0.008 0.0001 % square root
eosinophils 1613 0.166 0.0027 2062 0.164 0.0027 G/l square root
eosinophils % 1613 0.027 0.0004 2062 0.027 0.0004 % square root
lymphocytes 1611 1.983 0.0147 2062 1.875 0.0284 G/l square root
lymphocytes % 1611 0.330 0.0019 2062 0.313 0.0018 % –
monocytes 1611 0.496 0.0039 2062 0.491 0.0038 G/l square root
monocytes % 1611 0.082 0.0004 2062 0.082 0.0004 % square root
neutrophils 1611 3.452 0.0343 2062 3.493 0.0300 G/l square root
neutrophils % 1611 0.551 0.0021 2062 0.567 0.0019 % –
Notes:
* similarly applied to values from both measurements.
** n with missing WBC values: 1021–1023 and 678–695.
*** n with missing WBC values: 1127–1130 and 640–679.
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counts in women) both positive and negative associations were apparent
during subsequent critical age ranges of trauma exposure. To facilitate
comparison of the results, the significant age of exposure snippets of all
WBC variables were plotted in Fig. 3 (a: men and b: women).
In men, eosinophil and lymphocyte counts remained persistently
increased for years or decades when the traumatic experience occurred in
childhood, both in terms of absolute values and proportions. The
neutrophil proportions counterbalanced these shifts. When the traumatic
experience occurred in adolescence, eosinophil levels remained persis-
tently high, counterbalanced by decreased neutrophil counts. In
adulthood, the latter were accompanied by decreased basophil counts
and proportions.
In women, all main WBC, i.e., lymphocytes, eosinophils and
neutrophils – and thus the overall leukocyte counts – showed persistently
increased levels for trauma in childhood. Lymphocytes and eosinophils
exhibited increased levels for trauma in adolescence, the latter also for
trauma in young adulthood. Here, in women's twenties, decreased levels
of monocytes and lymphocytes (both in terms of absolute levels and
proportions) were apparent. In their thirties, decreased levels of
lymphocytes (proportions) were counterbalanced by neutrophils
(proportions).
Discussion
This study examined WBC count levels related to age of exposure to
trauma in PTSD with a novel procedure based on cross-sectional data. The
results suggest that WBC counts are among those markers that become
shifted due to trauma exposure and retain increased / decreased levels
across the life-span. It has been shown that the total WBC count reflects
the severity of PTSD over one or several years [18]. This study showed
that shifted levels can be identified even decades later. In both men and
women, three similar configurations become apparent through the
backtrace procedure: a strong immune response to trauma exposure in
childhood, an attenuated response in adolescence and a weaker, partly
inverse response in adulthood.
In subjects who experienced traumatic events during childhood and
early adolescence, the immune system response resulting in partial / full
PTSD was characterized by persistently increased WBC counts:
lymphocytes, eosinophils – in women also neutrophils. The latter detail
is particularly revealing, since lymphocytes and neutrophils often show a
complementary relation in terms of proportions (see also the configura-
tion in men). It can be assumed that the trauma outcome is more severe if
the levels of several WBC groups are increased. Parenthetically, the
stronger (and longer) involvement of WBC in women adds a new
interpretation for why women experience more severe outcomes than
men after trauma exposure, even if the trauma type is the same [19].
Overall, the WBC response to traumatic events resembled that to serious
infectious challenges [20,21].
In young adulthood, this strong response smoothed out and was
replaced by suppressed WBC levels: neutrophils and basophils in men,
lymphocytes and monocytes in women. This emerging pattern possibly
reflects a response of the WBC to an upregulation of the hypothalamic–
pituitary–adrenal axis that is similar to leukopenia in hypercortisolism
[22]. This interpretation remains to be corroborated by further research.
In the PTSD research literature, the most frequently reported
deviation of WBC counts relates to increased lymphocyte levels and
sometimes neutrophil or total leukocyte levels [23,24]. The assessments
mostly derive from studies on veterans [1,25,26]. They can be time-
lagged by up to 20 years [27,28], thus providing a preliminary template
for the backtrace approach. In contrast to lymphocytes, the relationship
between trauma exposure and eosinophils [29] and related conditions
such as seasonal allergies and atopic diseases [30,31] has gained less
attention. Actually, studies in the aftermath of the 9/11 tragedy showed
that PTSD predicts asthma incidence [32].
To summarize the PTSD-relevant results, this study showed that the
WBC-related part of the immune response after trauma exposure must be
more complex than earlier studies with limited samples have reported,
more multifarious in women than in men, and stronger and more
Table 2
z-standardized white blood cell counts in men and women with partial / full PTSD;
p-values refer to t-tests against subjects without trauma exposure.
N mean SE p-value
men*
leukocytes 91 .1178 .09073 .219
basophils 91 .1332 .08322 .114
basophils % 91 .0951 .08522 .258
eosinophils 91 .0876 .10167 .328
eosinophils % 91 .1319 .09974 .152
lymphocytes 91 .0983 .09302 .307
lymphocytes % 91 .2406 .09340 .010
monocytes 91 .0783 .09553 .355
monocytes % 91 .0335 .09262 .776
neutrophils 91 .2080 .07722 .023
neutrophils % 91 .2602 .09375 .005
women**
leukocytes 195 .2003 .06179 .000
basophils 194 .0694 .05906 .189
basophils % 193 .0044 .05630 .822
eosinophils 192 .0869 .06848 .140
eosinophils % 194 .0479 .06748 .443
lymphocytes 194 .0803 .05946 .114
lymphocytes % 193 .0867 .06465 .215
monocytes 193 .0603 .06373 .323
monocytes % 191 .1332 .05721 .029
neutrophils 193 .1840 .06340 .002
neutrophils % 193 .1190 .06299 .070
Notes:
* n with missing WBC values (no measurement at all): 19.
** n with missing WBC values (no measurement at all): 37–41.
Table 3
p-values of t-tests for overall and age-range specific white blood cell count data,
tests against subjects without trauma exposure.
overall specific age ranges
p-value p-value above ref. below ref. n
men
leukocytes .219
basophils 3 .114 .011 2133 29
basophils % 3 .258 .014 2233 27
eosinophils 3 .328 .018 921 35
eosinophils % 35 .152 .008 921 35
lymphocytes 35 .307 .002 813 17
lymphocytes % 3<5 .010 .003 813 17
monocytes .355
monocytes % .776
neutrophils 35 .023 .042 1335 56
neutrophils % 3<5 .005 .003 813 17
women
leukocytes 3 .000 .000 414 74
basophils .189
basophils % .822
eosinophils 3 .140 .010 627 110
eosinophils % 3 .443 .007 2127 25
lymphocytes 35 .114 .000 421 104
.024 2235 48
lymphocytes % 35 .215 .024 2235 48
monocytes 35 .323 .012 2327 18
monocytes % 35 .029 .005 1928 39
neutrophils 35 .002 .000 513 63
neutrophils % 35 .070 .037 2635 35
Notes:
3 selection of the critical age range based on 3-year moving average.
35 selection of the critical age range based on equal 3-year and 5-year moving
average.
3 < 5 selection of the critical age range based on 5-year over 3-year moving
average due to lower p-value.
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persistent in younger developmental stages. In terms of WBC counts,
PTSD in childhood and PTSD in adulthood represent different disorders
despite being classified in the same way by symptoms, duration, burden,
etc.
Interpretation variants for backtraced biomarkers
So far, we have adapted the most natural interpretation, namely that
trauma experiences lead to physiological up- or downregulations [23].
Some of these changes might be transient and disappear (e.g., cortisol
levels, natural killer cell cytotoxicity, glucocorticoid receptor expression
[1]), while others such as the WBC counts in this study are presumed to
"freeze", persist for a long time and also be measurable later in life. In the
current context of this study, we refrain from specifying the causal
implications: Do the up- or downregulations of WBC contribute to the
development of severe symptoms and finally of PTSD? Or do they
passively reflect more relevant up- or downregulations that were not
investigated in the current analysis?
However, there are alternative interpretation options to be considered
even on a formal methodological level. The first one suggests that the
trauma experience interacts with a biomarker level at any specific stage of
development by interrupting its successive change. This could result either
in delaying developmental processes or simply in freezing current system
states. In both instances, i.e., interrupting change or freezing, the marker
levels, as measured years later, wouldsystematically remain below or above
the normal age-specific levels at the time of measurement. The latter notion
might be combined with the hypothesis that more severe outcomes after
trauma exposure reflect pre-existing high / low marker levels, e.g. a pre-
existingpro-inflammatory state [33]. However, inviewofmarker shifts that
also occur in less severe outcomes, this hypothesis holds little promise.
Another interpretation option brings secondary processes into focus.
Here, the shifted marker levels are comprehensible as physiological
Fig. 3. Shifted white blood cell counts and proportions in partial / full PTSD across the age of trauma exposure in men (a) and women (b).
Notes: Bold lines denote 0.01- significance level, thin lines the 0.05 level. The y axis only contains the information as to whether an age snippet has a
significantly lower or higher level than the reference value. The snippets, since derived from z-standardized values, were sorted out in order to facilitate the
interpretation of the results. Their relative position above or below the reference value, respectively, is arbitrary.
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aftereffects of PTSD [34] or even as proxies for remission mechanisms. It
is also imaginable that they increase / decrease in the course of time.
Secondary processes can be expected to be more generalizing than
processes directly related to trauma exposure. They can be assumed to
consistently represent the severity of PTSD across different outcomes and
to preferably cover extended age ranges. This cannot be definitively
excluded in any biomarker series that is censored (limited) by the upper
age limit in the analysis.
Studies on links between biomarkers and mental disorders have
documented bidirectional relations between inflammatory markers and
anxiety disorders [35] or between hypotension and affective disorders
[36–38]. Thus, it seems wise to explore all options mentioned above in
order to interpret the lasting marker shifts. Where developmental stages
are reflected in the results through limited age ranges, attention is mainly
pulled towards the first option (trauma exposure –> biomarker shifts –>
PTSD). In censored markers, the third option (trauma exposure –> PTSD
–> biomarker shifts) also deserves particular attention.
Methodological implications
The backtrace procedure allows the study of age-of-onset-dependent
processes based on cross-sectional data. This opens new perspectives for
large cross-sectional studies if, as is mostly the case, large longitudinal
surveys covering long periods are lacking.
The particular advantage of the backtrace procedure is at the same
time a major source of limitations. Markers that are only temporarily
shifted [39] cannot be determined by this approach. Also, the
categorization of markers into primary or secondary processes (see
above) is not straightforward. Future research will show how chronic /
recovered PTSD [40] is reflected in persistently shifted markers
depending on onset across different developmental stages as well as
which comorbidity patterns are linked to the different combinations.
The backtrace procedure is not limited to PTSD, but can be applied to
other mental disorders as well as to somatic conditions such as chronic
inflammatory, autoimmune and atopic diseases. PTSD was particularly
suited for developing such a procedure, since it comes with an exogenous
trigger (i.e., trauma exposure) and offers the full range of outcomes (no PTS
symptoms, PTS symptoms, diagnosis). In most mental disorders and chronic
inflammatory / autoimmune diseases, the onset triggers are not known, and
the analysis will be limited to symptom and diagnosis level outcomes.
Apart from these practical issues there are more basic ones. The
backtrace procedure is a tool for exploring heterogeneity as is latent class
analysis and other pattern-recognition approaches typically implemented
by person-centered models [41–44]. Although here the focus was solely on
WBC, it has become clear that different mechanisms contribute to the
disorder labeled as PTSD. Including further markers will extend the range
of mechanisms involved even more. Furthermore, specific designs for
heterogeneity-targeting research are still underdeveloped and underused.
Dealing with heterogeneity and complexity carries with it not only
conceptual but also statistical challenges. Regarding inferential statistics,
this study thwarted the currently popular notion that more rigid p-values
would generally improve research quality [45]. The backtrace procedure
suggested that even the "soft" 0.05-p-value norms turn out to be inferior
when applied to a heterogeneous target such as PTSD. Many associations
in PTSD that deserve a second glance became apparent only after a
differentiation along developmental stages had been introduced. Rigidly
introduced p-values provide no support in anticipating necessary
differentiation steps in complex disorders.
Strengths and weaknesses of this study
The big sample of the CoLaus|PsyCoLaus survey and the wealth of data
on somatic and psychiatric conditions, including biomarker data, is a rich
source for pattern recognition analyses. Nevertheless, if the subgroups in
the analyses became small, the CoLaus|PsyCoLaus sample turned out to
be limited. This occurred despite using moving averages and grouping in
order to smooth the data (see, for example, results related to different
outcomes in adulthood). Clearly, the backtrace procedure relies on large
case numbers since it differentiates the cases by (exposure or onset) age
years. To reach satisfying case numbers for the present analysis, data from
full and partial PTSD were pooled together. This might have smoothed the
outcomes to some extent.
The PTSD questionnaire section in CoLaus|PsyCoLaus carries the
limitation that it is focused on the most severe traumatic event. The only
exception is sexual abuse, which was asked about separately. Therefore,
how previous or subsequent traumatic events interfered with the results
[46] could not be controlled for in this analysis. The PTSD questionnaire
section also did not allow conclusions about trauma exposures in infancy
(see for example [47]). Due to limited recall of events occurring before the
age of three [48], events reported from this age period or "as early as I can
remember" were randomly assigned to age 3–5 years. Based on the
instrument, upon which the PTSD questionnaire section of CoLaus|
PsyCoLaus was based (the SADS-LA), no more than five types of trauma
exposure were included.
An important advantage of the CoLaus|PsyCoLaus study compared to
most other studies is the multiple assessment of markers. The poor inter-
correlations between neighbor measurements of the same marker
illustrate an enormous amount of noise in the biomarker data. In this
study with 5-year lags between measurements, they were in the range of
0.450.75 in WBC counts.
This study shares further common limitations of studies based on self-
reporting data. Due to the recall bias known as a telescoping effect [49] –
a remote onset age is typically pulled forward on the time scale by up to 3
years – the age of exposure and, accordingly, the developmental stages
might occur slightly earlier than indicated. In addition, round numbers
were more frequently reported than others.
Conclusions
Many biomarker shifts after trauma exposure such as those of WBC
counts are retained across the life-span in persons with PTSD. Their
profiles can be reconstructed by tracing back marker values to the age of
exposure. Together with the marker profiles, different etiopathogenetic
mechanisms become visible. In this study, WBC-related mechanisms in
PTSD were shown to depend on developmental stage, thus contributing to
the heterogeneity of trauma outcomes. The backtrace procedure
presented in this study provides the key to a better understanding of
this heterogeneity. It opens new perspectives for large cross-sectional
studies if, as is mostly the case, longitudinal data covering long age ranges
are not available. As in PTSD, the backtrace approach could also be
applied to identifying persistent biomarker profiles in other mental
disorders, as well as autoimmune and other chronic diseases.
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Appendix A
Procedure description: Details of the backtrace procedure, steps 3 and 4
In the following, steps 3 and 4 of the analysis flowchart (see Fig. 2 of
the main text), which serve to determine critical age periods, are
described in more detail and illustrated by an example.
Step three was based on an exploratory graphic display, shown in
Fig. A1. The time series (red line, with t-test confidence intervals = green
lines) represent the mean levels of a marker X at the age when a traumatic
event was experienced. The reference value (blue line) represents the
overall mean level of the same marker in subjects who did not experience
any trauma; their marker level is constant.
The time series of marker X was smoothed by a moving average (MA)
age period in order to avoid erratic curves and problems with small Ns
when calculating the confidence intervals. The mean levels of marker X
were calculated in this example for a 9-year MA (see issue 1 in the Fig. A1 ;
the x-axis represents the age, i.e., the middle year of each successive 9-
year age period; for example, the mean level of marker X at age 20
corresponds to the mean level of all subjects who experienced a traumatic
event in the age period 16–24 years). As illustrated in this example, the
mean levels of marker X are particularly low in subjects who experienced
a traumatic event after age 22, as indicated by the upper confidence
interval of the t-tests for the following age years, which fell below the
mean of the marker in subjects who did not experience any trauma.
After visual inspection, a data-driven iterative procedure served to
identify the peaks and lows in the data together with the best fitting
critical age ranges surrounding each peak or low. The next analysis step
started by determining the 'point of maximal divergence in each marker
(see issue 2 in Fig. A1 ; in the schematic example the point of maximal
divergence, i.e., the low, is at 30 years). This is the maximal difference
Fig. A1. Illustration of steps 3 and 4 of the backtrace procedure.
Fig. A2. The critical age period.
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between the mean levels of a marker X by age and the reference value. For
some markers, it was possible to identify both a low and a peak of maximal
divergence. The 'point of maximal divergence' was not determined based
on raw marker levels but on smoothed data in order to exclude outliers
from the selection procedure. Smoothing was based on moving averages,
e.g. 3- / 5- / 7-age year moving averages. It is possible to consider and
include results from different moving averages in order to obtain the most
comprehensive selection of markers.
Markers for which there was no significant difference between the two
means at any age at onset, and which did not reveal a significant overall
difference in their means, were excluded from the subsequent analysis
steps. For those markers, it is assumed that differences in age at onset do
not play a role. Exceptions were accepted if the overall test was significant
(see step 2 in the analysis flowchart (Fig. 2 in the main text)).
In step 4 of the procedure, as depicted in the analysis flowchart, a set of
period variables were created based on the point of maximal divergence,
in order to represent all possible periods that include the point of maximal
divergence (see issue 3 in Fig. A1). Up to 200 new variables were created
per marker. To give an example, variable ‘30_31’ includes the values of
marker X of those participants who experienced a traumatic event within
the period 30–31. It excludes the values of participants who were exposed
to trauma outside this period; their values were set to missing. The same
procedure was applied to all other possible periods, including the age of
maximal divergence, i.e., 30 (for example 30_32, 26_34, 12_34 etc.).
For each period variable, a t-test was applied to compare the values
against the reference value. The period variable with the lowest p-value
was assumed to most likely indicate the "best" critical age period for
marker X (see Fig. A2). Further criteria for the selection included a
sufficient period width (at least the MA range) and a minimal N (N greater
than or equal to 10).
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